ATE320424T1 - Verfahren zu herstellung von citalopram - Google Patents

Verfahren zu herstellung von citalopram

Info

Publication number
ATE320424T1
ATE320424T1 AT01910007T AT01910007T ATE320424T1 AT E320424 T1 ATE320424 T1 AT E320424T1 AT 01910007 T AT01910007 T AT 01910007T AT 01910007 T AT01910007 T AT 01910007T AT E320424 T1 ATE320424 T1 AT E320424T1
Authority
AT
Austria
Prior art keywords
formula
sub
compound
citalopram
sup
Prior art date
Application number
AT01910007T
Other languages
English (en)
Inventor
Alan Kenneth Greenwood
Derek Mchattie
Josef Antonin Rechka
Paul Christopher Markus Hedger
Mark Philip Gamble
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Application granted granted Critical
Publication of ATE320424T1 publication Critical patent/ATE320424T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT01910007T 2000-03-07 2001-03-07 Verfahren zu herstellung von citalopram ATE320424T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0005477.5A GB0005477D0 (en) 2000-03-07 2000-03-07 Process for the preparation of citalopram

Publications (1)

Publication Number Publication Date
ATE320424T1 true ATE320424T1 (de) 2006-04-15

Family

ID=9887136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01910007T ATE320424T1 (de) 2000-03-07 2001-03-07 Verfahren zu herstellung von citalopram

Country Status (13)

Country Link
US (1) US7002025B2 (de)
EP (1) EP1268461B1 (de)
CN (1) CN1216049C (de)
AT (1) ATE320424T1 (de)
AU (2) AU3759101A (de)
BR (1) BR0109048A (de)
CA (1) CA2401861A1 (de)
DE (1) DE60117963D1 (de)
GB (1) GB0005477D0 (de)
NO (1) NO20024241L (de)
NZ (1) NZ521172A (de)
WO (1) WO2001066536A1 (de)
ZA (1) ZA200206914B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
HRP20020344B1 (hr) 1999-10-25 2010-10-31 H. Lundbeck A/S Način priprave citaloprama
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
HUP0203635A3 (en) 1999-12-28 2005-02-28 Lundbeck & Co As H Method for the preparation of citalopram
PT1246813E (pt) 1999-12-30 2004-02-27 Lundbeck & Co As H Metodo para a preparacao de citalopram
CN1195749C (zh) 2000-01-14 2005-04-06 H.隆德贝克有限公司 制备5－氰基2－苯并[c]呋喃酮的方法
IT1317729B1 (it) 2000-01-18 2003-07-15 Norpharma S P A Procedimento per la preparazione della 5-carbossiftalide.
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
KR20020080481A (ko) 2000-03-13 2002-10-23 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조 방법
CN1427835A (zh) 2000-03-13 2003-07-02 H·隆德贝克有限公司 5－取代的1－(4－氟苯基)－1,3－二氢异苯并呋喃的分步烷基化
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
TR200202155T2 (tr) 2000-03-14 2002-12-23 H. Lundbeck A/S Sitalopramin preparasyon metodu
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2354877C (en) * 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
WO2001045483A2 (en) 2000-12-22 2001-06-28 H. Lundbeck A/S Method for the preparation of pure citalopram
JP2003519121A (ja) 2000-12-28 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット 純粋なシタロプラムの製造方法
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
CN106083786A (zh) * 2016-07-07 2016-11-09 孙冉 一种酰基呋喃类医药中间体化合物的合成方法
CN106187965B (zh) * 2016-07-07 2019-02-12 上海博栋化学科技有限公司 一种药物中间体双环呋喃类化合物的合成方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607884A (en) 1969-03-11 1971-09-21 Mobil Oil Corp Preparation of 5-carboxyphthalide in liquid sodium trioxide
DE2242007A1 (de) 1972-08-26 1974-03-14 Basf Ag Verfahren zur herstellung von phthalimidinen
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
DE2630927A1 (de) 1976-07-09 1978-01-19 Basf Ag Verfahren zur herstellung von phthalidcarbonsaeure-(5)
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
HU212435B (en) 1990-06-07 1996-06-28 Sandoz Ag Herbicidal compositions containing substituted phthalides and heterocyclic phthalides as active ingredient and process for preparation of their active ingredients.
US6204284B1 (en) 1991-12-20 2001-03-20 American Cyanamid Company Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies
GB9325360D0 (en) 1993-12-10 1994-02-16 Univ Bristol Organic compounds
JPH11513382A (ja) 1995-10-20 1999-11-16 ドクトル カルル トーマエ ゲゼルシャフト ミット ベシュレンクテル ハフツング ５員複素環化合物、これらの化合物を含む医薬品、それらの使用及びそれらの調製方法
DE19539091A1 (de) 1995-10-20 1997-04-24 Thomae Gmbh Dr K 5-gliedrige Heterocyclen, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zur ihrer Herstellung
US5691362A (en) 1996-06-05 1997-11-25 Schering-Plough Corporation Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
ES2148120T3 (es) * 1997-07-08 2002-01-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
EA002770B1 (ru) 1997-11-11 2002-08-29 Х.Лундбекк А/С Способ получения циталопрама
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
JP3827530B2 (ja) 1998-12-16 2006-09-27 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 置換アリール誘導体及び置換ヘテロアリール誘導体、それらの調製及び薬物としてのそれらの使用
DK1173431T4 (da) * 1999-04-14 2010-01-04 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
EP1220658A1 (de) 1999-09-28 2002-07-10 H. Lundbeck A/S Schmelzgranulierte zusammensetzung und aus dieser hergestellte darreichungsform mit modifizierter freisetzung
WO2001032643A1 (en) 1999-11-01 2001-05-10 H. Lundbeck A/S Method for the preparation of 5-carboxyphthalide
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
AU3789901A (en) 1999-12-17 2001-06-25 Bristol-Myers Squibb Company Antipsychotic heterocycle compounds
HUP0203635A3 (en) 1999-12-28 2005-02-28 Lundbeck & Co As H Method for the preparation of citalopram
PT1246813E (pt) 1999-12-30 2004-02-27 Lundbeck & Co As H Metodo para a preparacao de citalopram
CN1195749C (zh) 2000-01-14 2005-04-06 H.隆德贝克有限公司 制备5－氰基2－苯并[c]呋喃酮的方法
IT1317729B1 (it) 2000-01-18 2003-07-15 Norpharma S P A Procedimento per la preparazione della 5-carbossiftalide.
US6433196B1 (en) 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
IES20010143A2 (en) 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.

Also Published As

Publication number Publication date
US7002025B2 (en) 2006-02-21
NO20024241D0 (no) 2002-09-05
CN1216049C (zh) 2005-08-24
BR0109048A (pt) 2003-06-03
ZA200206914B (en) 2004-11-29
NO20024241L (no) 2002-11-07
EP1268461B1 (de) 2006-03-15
US20040014997A1 (en) 2004-01-22
GB0005477D0 (en) 2000-04-26
WO2001066536A1 (en) 2001-09-13
NZ521172A (en) 2004-05-28
CA2401861A1 (en) 2001-09-13
DE60117963D1 (de) 2006-05-11
AU2001237591B2 (en) 2005-05-19
EP1268461A1 (de) 2003-01-02
AU3759101A (en) 2001-09-17
CN1427834A (zh) 2003-07-02

Similar Documents

Publication Publication Date Title
ATE320424T1 (de) Verfahren zu herstellung von citalopram
ATE340790T1 (de) Verfahren zu herstellung von 2-(6-substituierte-1,3-dioxan-4-yl)essigsäurede ivate
ATE205824T1 (de) Verfahren zur herstellung von citalopram
CA2356188A1 (en) Method for the preparation of 5-cyanophthalide
RU93004874A (ru) 13,14-ДИГИДРО-15(R)-17-ФЕНИЛ-18, 19, 20-ТРИНОР- PGF2α СПОСОБ ПОЛУЧЕНИЯ ИХ СЛОЖНЫХ ЭФИРОВ И ЦИКЛОПЕНТА (В) ФУРАНОВЫЕ ПРОИЗВОДНЫЕ
EP0738703A3 (de) Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
SK1452000A3 (en) Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
ATE244718T1 (de) Verfahren zur herstellung von azabicyclische derivaten
ATE90676T1 (de) Dioxyalkylenaryl-dihydropyridine zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung.
ATE277015T1 (de) Verfahren zur herstellung von 1,4-dihydropyridine sowie in diesem verfahren verwendete verbindungen
EA200200939A1 (ru) Способ получения циталопрама
ES8607218A1 (es) Un procedimiento para preparar compuestos de amidina
DE60101786D1 (de) Verfahren zur herstellung von citalopram
RU2001113272A (ru) 3-тетрагидропиридин-4-илиндолы для лечения психотических нарушений
IS6636A (is) Hringlaga ketonar og notkun þeirra í smíði amínósýra
AR029893A1 (es) Metodo para la preparacion de citalopram, intermediarios y composicion farmaceutica
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
ATE239017T1 (de) 1,4-dihydropyridin-5-carbonsäureester-derivate und verfahren zu ihrer herstellung
BG103328A (en) Method for the preparation of n-[2-(dimethylamino)ethyl]-acridine-4-carboxamide
RU97118593A (ru) ПРОИЗВОДНЫЕ 1-[ω-(3,4-ДИГИДРО-2-НАФТАЛИНИЛ)АЛКИЛ] ЦИКЛИЧЕСКОГО АМИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
RU95122160A (ru) Способ получения ng-моноалкил-l-аргинина и родственных соединений
DK1257523T3 (da) Fremgangsmåde til fremstilling af 3-aminoalkansyreestere
JPS55122758A (en) Racemization of l-alpha-methyl-beta-acylthiopropionic acid
ATE247632T1 (de) Verfahren zur herstellung von cyanessigsäureestern
DE59001784D1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties